お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、オリゴヌクレオチドAPIの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にオリゴヌクレオチドAPI市場を分類しています。
本レポートでは世界のオリゴヌクレオチドAPI市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Jazz Pharmaceuticals、Sarepta Therapeutics、Biogen、Dynavax Technologies、Akcea Therapeutics、Alnylam Pharmaceuticals、Nitto Denko (Avecia)、Ajinomoto (GeneDesign)、RiboBio

レポートはオリゴヌクレオチドAPIの主要生産者を調査し、主要地域や国の消費状況も提供します。オリゴヌクレオチドAPIの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Antisense Oligonucleotides API
    Small Interfering RNA (siRNA) API
    MiRNA API
    CpG Oligonucleotides API
    Others

用途別の市場セグメント：
    Contract Manufacturing Organizations (CMOs)
    Pharmaceutical Companies

本レポートの詳細内容
本レポートは、世界のオリゴヌクレオチドAPI市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてオリゴヌクレオチドAPI市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のオリゴヌクレオチドAPI生産量、成長率、市場シェアを調査している。

二. 消費面では、オリゴヌクレオチドAPIの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのオリゴヌクレオチドAPI売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のオリゴヌクレオチドAPI市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本オリゴヌクレオチドAPIのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：オリゴヌクレオチドAPIのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： オリゴヌクレオチドAPIの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるオリゴヌクレオチドAPIの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章オリゴヌクレオチドAPIメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：オリゴヌクレオチドAPIの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：オリゴヌクレオチドAPIの主要メーカーの概要を提供し、製品の説明と仕様、オリゴヌクレオチドAPIの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：オリゴヌクレオチドAPIの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Oligonucleotide API market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oligonucleotide API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Oligonucleotide API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Oligonucleotide API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Oligonucleotide API include Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals, Nitto Denko (Avecia), Ajinomoto (GeneDesign) and RiboBio, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Oligonucleotide API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Oligonucleotide API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Oligonucleotide API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Oligonucleotide API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Oligonucleotide API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oligonucleotide API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oligonucleotide API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oligonucleotide API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals, Nitto Denko (Avecia), Ajinomoto (GeneDesign) and RiboBio, etc.

Market Segmentation
By Company
    Jazz Pharmaceuticals
    Sarepta Therapeutics
    Biogen
    Dynavax Technologies
    Akcea Therapeutics
    Alnylam Pharmaceuticals
    Nitto Denko (Avecia)
    Ajinomoto (GeneDesign)
    RiboBio

Segment by Type
    Antisense Oligonucleotides API
    Small Interfering RNA (siRNA) API
    MiRNA API
    CpG Oligonucleotides API
    Others

Segment by Application
    Contract Manufacturing Organizations (CMOs)
    Pharmaceutical Companies

Production by Region
    North America
    Europe
    China
    Japan

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Oligonucleotide API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Oligonucleotide API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oligonucleotide API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotide API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

List of Tables
    Table 1. Global Oligonucleotide API Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Antisense Oligonucleotides API
    Table 3. Major Manufacturers of Small Interfering RNA (siRNA) API
    Table 4. Major Manufacturers of MiRNA API
    Table 5. Major Manufacturers of CpG Oligonucleotides API
    Table 6. Major Manufacturers of Others
    Table 7. Global Oligonucleotide API Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Oligonucleotide API Production by Region: 2019 VS 2023 VS 2030 (Ton)
    Table 9. Global Oligonucleotide API Production by Region (2019-2024) & (Ton)
    Table 10. Global Oligonucleotide API Production by Region (2025-2030) & (Ton)
    Table 11. Global Oligonucleotide API Production Market Share by Region (2019-2024)
    Table 12. Global Oligonucleotide API Production Market Share by Region (2025-2030)
    Table 13. Global Oligonucleotide API Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Oligonucleotide API Revenue by Region (2019-2024) & (US$ Million)
    Table 15. Global Oligonucleotide API Revenue by Region (2025-2030) & (US$ Million)
    Table 16. Global Oligonucleotide API Revenue Market Share by Region (2019-2024)
    Table 17. Global Oligonucleotide API Revenue Market Share by Region (2025-2030)
    Table 18. Global Oligonucleotide API Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Oligonucleotide API Sales by Region (2019-2024) & (Ton)
    Table 20. Global Oligonucleotide API Sales by Region (2025-2030) & (Ton)
    Table 21. Global Oligonucleotide API Sales Market Share by Region (2019-2024)
    Table 22. Global Oligonucleotide API Sales Market Share by Region (2025-2030)
    Table 23. Global Oligonucleotide API Sales by Manufacturers (2019-2024) & (Ton)
    Table 24. Global Oligonucleotide API Sales Share by Manufacturers (2019-2024)
    Table 25. Global Oligonucleotide API Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 26. Global Oligonucleotide API Revenue Share by Manufacturers (2019-2024)
    Table 27. Oligonucleotide API Price by Manufacturers 2019-2024 (US$/Ton)
    Table 28. Global Key Players of Oligonucleotide API, Industry Ranking, 2022 VS 2023 VS 2024
    Table 29. Global Oligonucleotide API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 30. Global Oligonucleotide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide API as of 2023)
    Table 31. Global Key Manufacturers of Oligonucleotide API, Manufacturing Base Distribution and Headquarters
    Table 32. Global Key Manufacturers of Oligonucleotide API, Product Offered and Application
    Table 33. Global Key Manufacturers of Oligonucleotide API, Date of Enter into This Industry
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Oligonucleotide API Sales by Type (2019-2024) & (Ton)
    Table 36. Global Oligonucleotide API Sales by Type (2025-2030) & (Ton)
    Table 37. Global Oligonucleotide API Sales Share by Type (2019-2024)
    Table 38. Global Oligonucleotide API Sales Share by Type (2025-2030)
    Table 39. Global Oligonucleotide API Revenue by Type (2019-2024) & (US$ Million)
    Table 40. Global Oligonucleotide API Revenue by Type (2025-2030) & (US$ Million)
    Table 41. Global Oligonucleotide API Revenue Share by Type (2019-2024)
    Table 42. Global Oligonucleotide API Revenue Share by Type (2025-2030)
    Table 43. Oligonucleotide API Price by Type (2019-2024) & (US$/Ton)
    Table 44. Global Oligonucleotide API Price Forecast by Type (2025-2030) & (US$/Ton)
    Table 45. Global Oligonucleotide API Sales by Application (2019-2024) & (Ton)
    Table 46. Global Oligonucleotide API Sales by Application (2025-2030) & (Ton)
    Table 47. Global Oligonucleotide API Sales Share by Application (2019-2024)
    Table 48. Global Oligonucleotide API Sales Share by Application (2025-2030)
    Table 49. Global Oligonucleotide API Revenue by Application (2019-2024) & (US$ Million)
    Table 50. Global Oligonucleotide API Revenue by Application (2025-2030) & (US$ Million)
    Table 51. Global Oligonucleotide API Revenue Share by Application (2019-2024)
    Table 52. Global Oligonucleotide API Revenue Share by Application (2025-2030)
    Table 53. Oligonucleotide API Price by Application (2019-2024) & (US$/Ton)
    Table 54. Global Oligonucleotide API Price Forecast by Application (2025-2030) & (US$/Ton)
    Table 55. US & Canada Oligonucleotide API Sales by Type (2019-2024) & (Ton)
    Table 56. US & Canada Oligonucleotide API Sales by Type (2025-2030) & (Ton)
    Table 57. US & Canada Oligonucleotide API Revenue by Type (2019-2024) & (US$ Million)
    Table 58. US & Canada Oligonucleotide API Revenue by Type (2025-2030) & (US$ Million)
    Table 59. US & Canada Oligonucleotide API Sales by Application (2019-2024) & (Ton)
    Table 60. US & Canada Oligonucleotide API Sales by Application (2025-2030) & (Ton)
    Table 61. US & Canada Oligonucleotide API Revenue by Application (2019-2024) & (US$ Million)
    Table 62. US & Canada Oligonucleotide API Revenue by Application (2025-2030) & (US$ Million)
    Table 63. US & Canada Oligonucleotide API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 64. US & Canada Oligonucleotide API Revenue by Country (2019-2024) & (US$ Million)
    Table 65. US & Canada Oligonucleotide API Revenue by Country (2025-2030) & (US$ Million)
    Table 66. US & Canada Oligonucleotide API Sales by Country (2019-2024) & (Ton)
    Table 67. US & Canada Oligonucleotide API Sales by Country (2025-2030) & (Ton)
    Table 68. Europe Oligonucleotide API Sales by Type (2019-2024) & (Ton)
    Table 69. Europe Oligonucleotide API Sales by Type (2025-2030) & (Ton)
    Table 70. Europe Oligonucleotide API Revenue by Type (2019-2024) & (US$ Million)
    Table 71. Europe Oligonucleotide API Revenue by Type (2025-2030) & (US$ Million)
    Table 72. Europe Oligonucleotide API Sales by Application (2019-2024) & (Ton)
    Table 73. Europe Oligonucleotide API Sales by Application (2025-2030) & (Ton)
    Table 74. Europe Oligonucleotide API Revenue by Application (2019-2024) & (US$ Million)
    Table 75. Europe Oligonucleotide API Revenue by Application (2025-2030) & (US$ Million)
    Table 76. Europe Oligonucleotide API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 77. Europe Oligonucleotide API Revenue by Country (2019-2024) & (US$ Million)
    Table 78. Europe Oligonucleotide API Revenue by Country (2025-2030) & (US$ Million)
    Table 79. Europe Oligonucleotide API Sales by Country (2019-2024) & (Ton)
    Table 80. Europe Oligonucleotide API Sales by Country (2025-2030) & (Ton)
    Table 81. China Oligonucleotide API Sales by Type (2019-2024) & (Ton)
    Table 82. China Oligonucleotide API Sales by Type (2025-2030) & (Ton)
    Table 83. China Oligonucleotide API Revenue by Type (2019-2024) & (US$ Million)
    Table 84. China Oligonucleotide API Revenue by Type (2025-2030) & (US$ Million)
    Table 85. China Oligonucleotide API Sales by Application (2019-2024) & (Ton)
    Table 86. China Oligonucleotide API Sales by Application (2025-2030) & (Ton)
    Table 87. China Oligonucleotide API Revenue by Application (2019-2024) & (US$ Million)
    Table 88. China Oligonucleotide API Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Oligonucleotide API Sales by Type (2019-2024) & (Ton)
    Table 90. Asia Oligonucleotide API Sales by Type (2025-2030) & (Ton)
    Table 91. Asia Oligonucleotide API Revenue by Type (2019-2024) & (US$ Million)
    Table 92. Asia Oligonucleotide API Revenue by Type (2025-2030) & (US$ Million)
    Table 93. Asia Oligonucleotide API Sales by Application (2019-2024) & (Ton)
    Table 94. Asia Oligonucleotide API Sales by Application (2025-2030) & (Ton)
    Table 95. Asia Oligonucleotide API Revenue by Application (2019-2024) & (US$ Million)
    Table 96. Asia Oligonucleotide API Revenue by Application (2025-2030) & (US$ Million)
    Table 97. Asia Oligonucleotide API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 98. Asia Oligonucleotide API Revenue by Region (2019-2024) & (US$ Million)
    Table 99. Asia Oligonucleotide API Revenue by Region (2025-2030) & (US$ Million)
    Table 100. Asia Oligonucleotide API Sales by Region (2019-2024) & (Ton)
    Table 101. Asia Oligonucleotide API Sales by Region (2025-2030) & (Ton)
    Table 102. Middle East, Africa and Latin America Oligonucleotide API Sales by Type (2019-2024) & (Ton)
    Table 103. Middle East, Africa and Latin America Oligonucleotide API Sales by Type (2025-2030) & (Ton)
    Table 104. Middle East, Africa and Latin America Oligonucleotide API Revenue by Type (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Oligonucleotide API Revenue by Type (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Oligonucleotide API Sales by Application (2019-2024) & (Ton)
    Table 107. Middle East, Africa and Latin America Oligonucleotide API Sales by Application (2025-2030) & (Ton)
    Table 108. Middle East, Africa and Latin America Oligonucleotide API Revenue by Application (2019-2024) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Oligonucleotide API Revenue by Application (2025-2030) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Oligonucleotide API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 111. Middle East, Africa and Latin America Oligonucleotide API Revenue by Country (2019-2024) & (US$ Million)
    Table 112. Middle East, Africa and Latin America Oligonucleotide API Revenue by Country (2025-2030) & (US$ Million)
    Table 113. Middle East, Africa and Latin America Oligonucleotide API Sales by Country (2019-2024) & (Ton)
    Table 114. Middle East, Africa and Latin America Oligonucleotide API Sales by Country (2025-2030) & (Ton)
    Table 115. Jazz Pharmaceuticals Company Information
    Table 116. Jazz Pharmaceuticals Description and Major Businesses
    Table 117. Jazz Pharmaceuticals Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 118. Jazz Pharmaceuticals Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Jazz Pharmaceuticals Recent Development
    Table 120. Sarepta Therapeutics Company Information
    Table 121. Sarepta Therapeutics Description and Major Businesses
    Table 122. Sarepta Therapeutics Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 123. Sarepta Therapeutics Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Sarepta Therapeutics Recent Development
    Table 125. Biogen Company Information
    Table 126. Biogen Description and Major Businesses
    Table 127. Biogen Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 128. Biogen Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Biogen Recent Development
    Table 130. Dynavax Technologies Company Information
    Table 131. Dynavax Technologies Description and Major Businesses
    Table 132. Dynavax Technologies Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 133. Dynavax Technologies Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Dynavax Technologies Recent Development
    Table 135. Akcea Therapeutics Company Information
    Table 136. Akcea Therapeutics Description and Major Businesses
    Table 137. Akcea Therapeutics Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 138. Akcea Therapeutics Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Akcea Therapeutics Recent Development
    Table 140. Alnylam Pharmaceuticals Company Information
    Table 141. Alnylam Pharmaceuticals Description and Major Businesses
    Table 142. Alnylam Pharmaceuticals Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 143. Alnylam Pharmaceuticals Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Alnylam Pharmaceuticals Recent Development
    Table 145. Nitto Denko (Avecia) Company Information
    Table 146. Nitto Denko (Avecia) Description and Major Businesses
    Table 147. Nitto Denko (Avecia) Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 148. Nitto Denko (Avecia) Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Nitto Denko (Avecia) Recent Development
    Table 150. Ajinomoto (GeneDesign) Company Information
    Table 151. Ajinomoto (GeneDesign) Description and Major Businesses
    Table 152. Ajinomoto (GeneDesign) Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 153. Ajinomoto (GeneDesign) Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Ajinomoto (GeneDesign) Recent Development
    Table 155. RiboBio Company Information
    Table 156. RiboBio Description and Major Businesses
    Table 157. RiboBio Oligonucleotide API Capacity Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 158. RiboBio Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. RiboBio Recent Development
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Oligonucleotide API Distributors List
    Table 163. Oligonucleotide API Customers List
    Table 164. Oligonucleotide API Market Trends
    Table 165. Oligonucleotide API Market Drivers
    Table 166. Oligonucleotide API Market Challenges
    Table 167. Oligonucleotide API Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oligonucleotide API Product Picture
    Figure 2. Global Oligonucleotide API Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oligonucleotide API Market Share by Type in 2023 & 2030
    Figure 4. Antisense Oligonucleotides API Product Picture
    Figure 5. Small Interfering RNA (siRNA) API Product Picture
    Figure 6. MiRNA API Product Picture
    Figure 7. CpG Oligonucleotides API Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Oligonucleotide API Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Oligonucleotide API Market Share by Application in 2023 & 2030
    Figure 11. Contract Manufacturing Organizations (CMOs)
    Figure 12. Pharmaceutical Companies
    Figure 13. Oligonucleotide API Report Years Considered
    Figure 14. Global Oligonucleotide API Capacity, Production and Utilization (2019-2030) & (Ton)
    Figure 15. Global Oligonucleotide API Production Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Oligonucleotide API Production Market Share by Region (2019-2030)
    Figure 17. Oligonucleotide API Production Growth Rate in North America (2019-2030) & (Ton)
    Figure 18. Oligonucleotide API Production Growth Rate in Europe (2019-2030) & (Ton)
    Figure 19. Oligonucleotide API Production Growth Rate in China (2019-2030) & (Ton)
    Figure 20. Oligonucleotide API Production Growth Rate in Japan (2019-2030) & (Ton)
    Figure 21. Global Oligonucleotide API Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 22. Global Oligonucleotide API Revenue 2019-2030 (US$ Million)
    Figure 23. Global Oligonucleotide API Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Figure 24. Global Oligonucleotide API Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 25. Global Oligonucleotide API Revenue Market Share by Region (2019-2030)
    Figure 26. Global Oligonucleotide API Sales 2019-2030 ((Ton)
    Figure 27. Global Oligonucleotide API Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Ton)
    Figure 28. Global Oligonucleotide API Sales Market Share by Region (2019-2030)
    Figure 29. US & Canada Oligonucleotide API Sales YoY (2019-2030) & (Ton)
    Figure 30. US & Canada Oligonucleotide API Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. Europe Oligonucleotide API Sales YoY (2019-2030) & (Ton)
    Figure 32. Europe Oligonucleotide API Revenue YoY (2019-2030) & (US$ Million)
    Figure 33. China Oligonucleotide API Sales YoY (2019-2030) & (Ton)
    Figure 34. China Oligonucleotide API Revenue YoY (2019-2030) & (US$ Million)
    Figure 35. Asia (excluding China) Oligonucleotide API Sales YoY (2019-2030) & (Ton)
    Figure 36. Asia (excluding China) Oligonucleotide API Revenue YoY (2019-2030) & (US$ Million)
    Figure 37. Middle East, Africa and Latin America Oligonucleotide API Sales YoY (2019-2030) & (Ton)
    Figure 38. Middle East, Africa and Latin America Oligonucleotide API Revenue YoY (2019-2030) & (US$ Million)
    Figure 39. The Oligonucleotide API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 40. The Top 5 and 10 Largest Manufacturers of Oligonucleotide API in the World: Market Share by Oligonucleotide API Revenue in 2023
    Figure 41. Global Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 42. Global Oligonucleotide API Sales Market Share by Type (2019-2030)
    Figure 43. Global Oligonucleotide API Revenue Market Share by Type (2019-2030)
    Figure 44. Global Oligonucleotide API Sales Market Share by Application (2019-2030)
    Figure 45. Global Oligonucleotide API Revenue Market Share by Application (2019-2030)
    Figure 46. US & Canada Oligonucleotide API Sales Market Share by Type (2019-2030)
    Figure 47. US & Canada Oligonucleotide API Revenue Market Share by Type (2019-2030)
    Figure 48. US & Canada Oligonucleotide API Sales Market Share by Application (2019-2030)
    Figure 49. US & Canada Oligonucleotide API Revenue Market Share by Application (2019-2030)
    Figure 50. US & Canada Oligonucleotide API Revenue Share by Country (2019-2030)
    Figure 51. US & Canada Oligonucleotide API Sales Share by Country (2019-2030)
    Figure 52. U.S. Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 53. Canada Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 54. Europe Oligonucleotide API Sales Market Share by Type (2019-2030)
    Figure 55. Europe Oligonucleotide API Revenue Market Share by Type (2019-2030)
    Figure 56. Europe Oligonucleotide API Sales Market Share by Application (2019-2030)
    Figure 57. Europe Oligonucleotide API Revenue Market Share by Application (2019-2030)
    Figure 58. Europe Oligonucleotide API Revenue Share by Country (2019-2030)
    Figure 59. Europe Oligonucleotide API Sales Share by Country (2019-2030)
    Figure 60. Germany Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 61. France Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 62. U.K. Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 63. Italy Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 64. Russia Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 65. China Oligonucleotide API Sales Market Share by Type (2019-2030)
    Figure 66. China Oligonucleotide API Revenue Market Share by Type (2019-2030)
    Figure 67. China Oligonucleotide API Sales Market Share by Application (2019-2030)
    Figure 68. China Oligonucleotide API Revenue Market Share by Application (2019-2030)
    Figure 69. Asia Oligonucleotide API Sales Market Share by Type (2019-2030)
    Figure 70. Asia Oligonucleotide API Revenue Market Share by Type (2019-2030)
    Figure 71. Asia Oligonucleotide API Sales Market Share by Application (2019-2030)
    Figure 72. Asia Oligonucleotide API Revenue Market Share by Application (2019-2030)
    Figure 73. Asia Oligonucleotide API Revenue Share by Region (2019-2030)
    Figure 74. Asia Oligonucleotide API Sales Share by Region (2019-2030)
    Figure 75. Japan Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 76. South Korea Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 77. China Taiwan Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 78. Southeast Asia Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 79. India Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 80. Middle East, Africa and Latin America Oligonucleotide API Sales Market Share by Type (2019-2030)
    Figure 81. Middle East, Africa and Latin America Oligonucleotide API Revenue Market Share by Type (2019-2030)
    Figure 82. Middle East, Africa and Latin America Oligonucleotide API Sales Market Share by Application (2019-2030)
    Figure 83. Middle East, Africa and Latin America Oligonucleotide API Revenue Market Share by Application (2019-2030)
    Figure 84. Middle East, Africa and Latin America Oligonucleotide API Revenue Share by Country (2019-2030)
    Figure 85. Middle East, Africa and Latin America Oligonucleotide API Sales Share by Country (2019-2030)
    Figure 86. Brazil Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 87. Mexico Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 88. Turkey Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 89. Israel Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 90. GCC Countries Oligonucleotide API Revenue (2019-2030) & (US$ Million)
    Figure 91. Oligonucleotide API Value Chain
    Figure 92. Oligonucleotide API Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed